wire - news in brief

« BACK

Life Sciences



Results 51 - 100 of 827.


Life Sciences - 23.08.2018
Movement control: how our brain responds to unexpected situations
Movement control: how our brain responds to unexpected situations
Scientists have demonstrated that the motor cortex is necessary for the execution of corrective movements in response to unexpected changes of sensory input but not when the same movements are executed spontaneously.

Health - Life Sciences - 03.08.2018
PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
European Medicines Agency PRIME (PRIority MEdicines) status is granted to medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients without treatment options RG6042 has the potential to be the first therapy targeting the underlying cause of Huntington's disease, a fatal neurodegenerative rare disease Third PRIME designation for a Roche medicine Roche today announced that the European Medicines Agency (E

Life Sciences - Environment - 25.07.2018
Scientists set out to explore microbial life in glacier streams
EPFL scientists will spend at least the next four years studying some of the world's biggest glacier-fed streams.

Health - Life Sciences - 23.07.2018
Novartis renews drug donation of Egaten (triclabendazole) until 2022, reaffirming its commitment to the fight against liver fluke
Novartis extends agreement with the WHO for the donation of Egaten for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 millio

Pharmacology - Life Sciences - 20.07.2018
Roche to present new data demonstrating the breadth and depth of its Alzheimer’s programme at the upcoming Alzheimer’s Association International Conference
Roche to present new data demonstrating the breadth and depth of its Alzheimer's programme at the upcoming Alzheimer's Association International Conference Late-breaking Phase II exploratory analysis

Life Sciences - Pharmacology - 20.07.2018
FDA grants Breakthrough Device Designation for Roche’s Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer’s disease
FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer's disease Roche announced today, that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.

Health - Life Sciences - 18.07.2018
Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women Kisqal

Life Sciences - 18.07.2018
New EMBO and HFSP fellows at FMI
This summer four FMI postdocs have been awarded an EMBO fellowship and one an HFSP fellowship. These fellowships spark huge interest among young researchers but are rare, and hard to get.

Life Sciences - 10.07.2018
Wyss Center showcases research at La Nuit de la Science
Wyss Center showcases research at La Nuit de la Science
Campus Biotech joined forces with La Nuit de la Science for the first time and welcomed visitors onto campus for the duration of the two-day event The Wyss Center team showcased a new virtual reality

Environment - Life Sciences - 05.07.2018
Improving small hydropower planning
Improving small hydropower planning
Small hydropower plants are often constructed on alpine streams, where they may have adverse impacts on sensitive ecosystems. Little is known, however, about the particular effects of individual plants, or the cumulative effects of multiple plants within the same river system. The current state of knowledge has now been reviewed in a study by Eawag researchers.

Health - Life Sciences - 29.06.2018
Novartis receives positive CHMP opinion for Kymriah for treating two aggressive blood cancers, marking important medical advance for patients in Europe
Novartis receives positive CHMP opinion for Kymriah for treating two aggressive blood cancers, marking important medical advance for patients in Europe First CHMP opinion for a CAR-T cell therapy in

Health - Life Sciences - 21.06.2018
Claudia Daubenberger Appointed Professor at the University of Basel
Claudia Daubenberger Appointed Professor at the University of Basel
The University of Basel appointed Claudia Daubenberger, Head of Clinical Immunology at Swiss TPH, as professor of Infection Biology and Immunology within the Faculty of Science.

Health - Life Sciences - 16.06.2018
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Overall response rate was 52% and median duration of response was not reached at a median follow-up of 14 months, signifying responses were durable   Patients had a 65% chance of being relapse-free o

Health - Life Sciences - 15.06.2018
Study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer Comparison of Jakavi (ruxolitinib) vs.

Health - Life Sciences - 14.06.2018
Enigma of fatty acid metabolism solved: Enzyme shape controls its activity
Enigma of fatty acid metabolism solved: Enzyme shape controls its activity
Fats are essential for our body. The core components of all fats are fatty acids. Their production is initiated by the enzyme ACC.

Life Sciences - Computer Science / Telecom - 29.05.2018

Life Sciences - Chemistry - 22.05.2018
Designer cells: artificial enzyme can activate a gene switch
Designer cells: artificial enzyme can activate a gene switch
Complex reaction cascades can be triggered in artificial molecular systems: Swiss scientists have constructed an enzyme than can penetrate a mammalian cell and accelerate the release of a hormone.

Health - Life Sciences - 17.05.2018
Novartis data at ASCO and EHA reinforce company’s commitment to reimagining cancer
Results from the Kisqali MONALEESA clinical trial program, the largest industrysponsored Phase III registration program researching a CDK4/6 inhibitor in HR+/HER2- advanced breast cancer, will be pre

Life Sciences - Health - 17.05.2018
Blocking two enzymes could make cancer cells mortal
EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening.

Life Sciences - Health - 16.05.2018
Cellular Valve Structure Opens Up Potential Novel Therapies
Cellular Valve Structure Opens Up Potential Novel Therapies
Human cells are enclosed by membranes and are in osmotic equilibrium with their environment. If the concentration of solute molecules (osmolarity) in the fluid surrounding the cells decreases, cells start to swell; in extreme cases, this can result in the cells bursting.

Life Sciences - 14.05.2018

Health - Life Sciences - 12.05.2018
Novartis announces FDA approval of Gilenya as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
New approval for Gilenya (fingolimod) addresses strong unmet need for younger patients, who often experience more frequent relapses than adults with multiple sclerosis (MS)   In a landmark controlled

Life Sciences - Health - 09.05.2018
Human MAIT cells sense the metabolic state of enteric bacteria
Human MAIT cells sense the metabolic state of enteric bacteria
A little-explored group of immune cells plays an important role in the regulation of intestinal bacteria. Changing metabolic states of the microbes have an effect on defense cells at different stages of alert or rest, as researchers from the Department of Biomedicine at the University and University Hospital of Basel report in the journal "Mucosal Immunology." It is known that the metabolites of bacteria influence the composition and function of immune cells resident within the gut.

Innovation / Technology - Life Sciences - 02.05.2018

Life Sciences - Health - 25.04.2018
How to profit from biowaste
How to profit from biowaste
April 25, 2018, Organisation & Staff Water & Development Researchers of the Eawag department Sanitation, Water and Solid Waste for Development (Sandec) and ETH Zurich are developing a method to produce animal feed from biowaste products.

Life Sciences - Event - 24.04.2018

Life Sciences - Health - 16.04.2018
Basel researchers succeed in cultivating cartilage from stem cells
Basel researchers succeed in cultivating cartilage from stem cells
Stable joint cartilage can be produced from adult stem cells originating from bone marrow.

Health - Life Sciences - 12.04.2018
Five proposals win initial
Five proposals win initial "catalyst" funding
Researchers from Campus Biotech were invited to develop joint projects with partner research institutes and bid for funding from the Bertarelli Foundation.

Life Sciences - Administration - 10.04.2018
Researcher Granted EUR 2.5 Million in Funding
Each year the European Research Council (ERC), open to both junior and established researchers, awards substantial funding for outstanding fundamental research.

Health - Life Sciences - 04.04.2018
Enhanced therapeutic vaccine platform achieves two proof of concepts in veterinary medical use
Enhanced therapeutic vaccine platform achieves two proof of concepts in veterinary medical use
Chronical allergic diseases of dogs and horses can now be treated with an innovative vaccine. It was developed by an international research team led by he University of Bern and in cooperation with the University of Zurich, together with private enterprise companies. The findings obtained in horses and dogs could lead to similar herapeutic vaccines for humans.

Health - Life Sciences - 04.04.2018
Therapeutic vaccine platform achieves proof of concepts in veterinary medical use
Scientists from the Universities of Bern, Zurich and Oxford as well as the Latvian Biomedical Research & Study Centre led by Prof. Martin F. Bachmann (University Clinic of Rheumatology, Immunoloy and Allergology, University of Bern) have developed a new therapeutic vaccine technology based upon enhanced virus like nanoparticle conjugates.

Health - Life Sciences - 26.03.2018
Healing instead of cutting down
Healing instead of cutting down
Trees can get sick too. In urban areas, this usually means that the infested tree has to be felled for safety reasons.

Health - Life Sciences - 23.03.2018
Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progressive MS
EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability progression in typical secondary progressive MS (SPMS) patients   Results demonstrate siponimod al

Health - Life Sciences - 22.03.2018
Novartis drug Tasigna approved by FDA to treat children with rare form of leukemia
Tasigna (nilotinib) approved for pediatric patients with newly diagnosed Ph+ CML-CP and children with Ph+ CML-CP resistant or intolerant to prior TKI therapy   New indication approved under FDA Prior

Health - Life Sciences - 21.03.2018

Health - Life Sciences - 21.03.2018
New Anti-Cancer Protein
New Anti-Cancer Protein
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver.

Health - Life Sciences - 20.03.2018

Life Sciences - Health - 19.03.2018
Paraplegic rats walk again after therapy, now we know why
Paraplegic rats walk again in response to neuroprosthetic rehabilitation that allows the brain to elaborate new routes so that motor commands about walking, swimming and even climbing staircases reach spinal cord execution centers below the injury. With the help of robot-assisted rehabilitation and electrochemical spinal cord stimulation, rats with clinically-relevant spinal cord injury regain control of their otherwise paralyzed limbs.

Life Sciences - 15.03.2018
Which Predators Make a Meal of Drosophila suzukii?
Which Predators Make a Meal of Drosophila suzukii?
Zurich-Reckenholz, 15.03.2018 - In search of native natural enemies of the exotic spotted-wing drosophila, Agroscope experts have developed a method for detecting its genetic material in the stomachs of predators. The spotted-wing drosophila (SWD or Drosophila suzukii ) is an introduced vinegar fly species that causes serious damage in Swiss crops.

Agronomy / Food Science - Life Sciences - 14.03.2018
Agroscope Celebrates 10th Anniversary of Global Seed Vault
Agroscope Celebrates 10th Anniversary of Global Seed Vault
Changins, 14.03.2018 - Agroscope went to Svalbard, Norway, to celebrate the tenth anniversary of the Global Plant Seed Vault, where over a million seed varieties from all around the world are stored in duplicate.

Environment - Life Sciences - 14.03.2018
Climate change drives mountain hares to higher altitudes
Climate change drives mountain hares to higher altitudes
A warming climate will shrink and fragment mountain hare habitat in the Swiss Alps. Populations are likely to decline as a result, concludes an international study led by the University of Bern and the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL). Specialised species like the mountain hare, adapted to life at high altitudes, are particularly affected by climate change.

Life Sciences - Health - 12.03.2018
Brain Awareness Week 2018
Brain Awareness Week 2018
From brain-controlled communication to reducing tinnitus through thought, this series of interviews with Wyss Center staff will put cutting edge neurotechnology in the spotlight.